Original Source(s)
Related Content
FDA Expands Test for Gastric and Esophageal Cancers
According to Agilent Technologies, the expanded indication covers esophageal and gastric tumor types and applies to patients being considered for nivolumab or nivolumab and hyaluronidase-nvhy.
July 14, 2026
-
2 min
Consensus Guidance May Improve Sinonasal Mass Outcomes
Multidisciplinary recommendations emphasize biopsy technique, imaging, and pathology review in patients with suspected sinonasal malignancy.
June 2, 2026
-
4 min
Rapid AST Speeds Care, Not Outcomes
Faster antibiotic optimization may still support use of rapid testing, particularly when paired with stewardship.
May 6, 2026
-
5 min